Sequence information
Variant position: 101 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 323 The length of the canonical sequence.
Location on the sequence:
VAKDNKILCNKCTTREDSPK
C KGCFKAIVAGDQNVEYKGTV
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human VAKDNK-----------------------------------------------------------------------------------------------ILCNKCTTREDSPKC K-------------------------------------------------------------------GCFKA-----------IVAGDQNV----EYKGTV
Mouse VSKDGK-----------------------------------
Rat VSKDGK-----------------------------------
Baker's yeast ILPEQERNDD-------------------------------
Fission yeast LLPEGSEEDGHLKETGITPLSLQQGKIAYSDEFGGKPTGSF
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 323
Four and a half LIM domains protein 1
Domain
101 – 153
LIM zinc-binding 2
Cross
86 – 86
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
Literature citations
Novel FHL1 mutations in fatal and benign reducing body myopathy.
Shalaby S.; Hayashi Y.K.; Nonaka I.; Noguchi S.; Nishino I.;
Neurology 72:375-376(2009)
Cited for: VARIANTS RBMX1A PHE-101 AND TYR-150; VARIANTS RBMX1B 102-LYS--CYS-104 DEL AND ARG-104;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.